Skip to main content

Relay Therapeutics, Inc.

RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001812364

In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.

Q4 2023 vs. Q3 2023

How the institutions holding Relay Therapeutics, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of RLAY: Q3 2023 compared with Q4 2023
MeasureQ3 2023Of which not filed for Q4 2023Q4 2023Change
Holders1723177+8
Shares130.5M26.1K127.2M−3.19M (−2.4%)
Value$1.10B$219.7K$1.40B+$304.1M (+27.7%)

3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Relay Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to RLAY in Q4 2023
InstitutionSharesValue% of portfolio
Affinity Asset Advisors, LLC300,000$3.30M0.66%
Susquehanna Portfolio Strategies, LLC210,003$2.31M0.04%
Public Employees Retirement System of Ohio98,413$1.08M0.00%
ExodusPoint Capital Management, LP82,761$911.0K0.01%
Man Group plc57,347$631.4K0.00%
TrueMark Investments, LLC47,958$528.0K0.52%
Pennant Investors, LP42,400$466.8K0.14%
Qube Research & Technologies Ltd34,962$384.9K0.00%
Royce & Associates LP32,025$352.6K0.00%
Franklin Resources Inc29,911$329.3K0.00%
Lazard Asset Management LLC29,669$326.0K0.00%
NEOS Investment Management LLC22,110$243.4K0.02%
Oracle Alpha Inc.18,716$206.1K0.27%
Gotham Asset Management, LLC16,135$177.6K0.00%
Nebula Research & Development LLC14,314$157.6K0.05%
Quest Partners LLC13,380$147.3K0.03%
Fox Run Management, L.L.C.12,191$134.2K0.03%
AQR Capital Management LLC11,501$126.6K0.00%
Victory Capital Management Inc11,467$126.3K0.00%
Amundi7,775$92.3K0.00%
Shell Asset Management Co7,484$82.0K0.00%
Acadian Asset Management LLC3,875$42.0K0.00%
US Bancorp1,828$20.1K0.00%
Smithfield Trust Co1,000$11.0K0.00%
Wetzel Investment Advisors, Inc.500$6.00K0.00%
C M Bidwell & Associates Ltd396$4.36K0.00%
Adirondack Trust Co344$3.45K0.00%
GAMMA Investing LLC369$3.41K0.00%
Private Wealth Management Group, LLC182$2.00K0.00%
Farther Finance Advisors, LLC100$1.10K0.00%
Capital Advisors, Ltd. LLC87$1.00K0.00%
Versant Capital Management, Inc78$8590.00%
The PNC Financial Services Group, Inc.46$5060.00%

Sold out (25)

Institutions that held Relay Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Not filed for Q4 2023 yet (3)

Institutions that held Relay Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RLAY in Q3 2023 that haven't filed for Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Virginia Retirement Systems Et Al14,500$121.9K
Quantamental Technologies LLC11,625$97.8K
Steward Financial Group LLC7$0